sulfinpyrazone has been researched along with Chronic Kidney Failure in 8 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Starting dosage was 200 mg per day; daily dosage was then increased, every 4 days, by 200 mg or kept constant for another 4 days, according to each patient's basal renal function, up to the maintenance dose: 800 mg/day." | 1.27 | Sulphinpyrazone in cardiovascular elderly azotemic patients: a proposal of a 'guided' incremental dose schedule. ( Borghi, C; Dacco', L; Di Ruvo, R; Palummeri, E; Passeri, M, 1984) |
| " Starting dosage was 200 mg per day; daily dosage was then increased every 4 days of 200 mg, or kept constant for another 4 days, according to each patient's renal function, up to 800 mg per day." | 1.27 | [Renal tolerance of an incremental dosage regimen of anturan in the aged with altered renal function]]. ( Bertolini, G; Borghi, C; Naliato, P, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palummeri, E | 1 |
| Borghi, C | 2 |
| Di Ruvo, R | 1 |
| Dacco', L | 1 |
| Passeri, M | 1 |
| Wizemann, V | 1 |
| Buddensiek, P | 1 |
| de Boor, J | 1 |
| Grebe, S | 1 |
| Schütterle, G | 1 |
| Boelaert, J | 1 |
| Schurgers, M | 1 |
| Daneels, R | 1 |
| Lijnen, P | 1 |
| Amery, A | 1 |
| Bern, MM | 1 |
| Green, J | 1 |
| Woods, HF | 1 |
| Ash, G | 1 |
| Parsons, V | 1 |
| Weston, MJ | 1 |
| Grzegorzewska, A | 1 |
| Antoniewicz, K | 1 |
| Kuźniak, J | 1 |
| Zawadzka, E | 1 |
| Opatrný, K | 2 |
| Cepelák, V | 1 |
| Valenta, J | 1 |
| Cepeláková, H | 1 |
| Sefrna, F | 1 |
| Bertolini, G | 1 |
| Naliato, P | 1 |
1 trial available for sulfinpyrazone and Chronic Kidney Failure
| Article | Year |
|---|---|
[Personal experience with the administration of sulfinpyrazone to patients with kidney failure].
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Kinet | 1986 |
7 other studies available for sulfinpyrazone and Chronic Kidney Failure
| Article | Year |
|---|---|
Sulphinpyrazone in cardiovascular elderly azotemic patients: a proposal of a 'guided' incremental dose schedule.
Topics: Aged; Cardiovascular Diseases; Drug Administration Schedule; Drug Tolerance; Female; Humans; Kidney | 1984 |
Gastrointestinal blood loss in patients undergoing maintenance dialysis.
Topics: Adult; Aged; Aluminum Hydroxide; Female; Heparin; Humans; Kidney Failure, Chronic; Male; Melena; Mid | 1983 |
Drug-induced renal failure.
Topics: Humans; Indomethacin; Kidney Failure, Chronic; Myocardial Infarction; Sulfinpyrazone | 1982 |
Effect of sulfinpyrazone upon antithrombin III and platelet factor 4 in chronic renal failure.
Topics: Adult; Aged; Antithrombins; Blood Coagulation Factors; Female; Humans; Kidney Failure, Chronic; Male | 1982 |
Reduction of dialyzer fibrin deposition with sulphinpyrazone.
Topics: Blood Platelets; Fibrin; Fibrinogen; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Sulfinpyr | 1979 |
[Effect of sulfinpyrazone on peritoneal and renal clearance in patients with chronic renal failure treated by intermittent peritoneal dialysis].
Topics: Adult; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; | 1990 |
[Renal tolerance of an incremental dosage regimen of anturan in the aged with altered renal function]].
Topics: Aged; Cerebrovascular Disorders; Coronary Disease; Creatinine; Dose-Response Relationship, Drug; Dru | 1985 |